Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program.

Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program. J Thromb Thrombolysis. 2012 Jul; 34(1):36-43.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.